Evidence map›Paper›PMID 38675968›Full record

ArticleViruses2024

Trends in and Risk Factors for Drug Resistance in

Xiaoqin Le, Xueqin Qian, Li Liu, Jianjun Sun, Wei Song, Tangkai Qi, Zhenyan Wang, Yang Tang, Shuibao Xu, Junyang Yang and 5 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Viruses · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Xiaoqin LeDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.ORCID 0000-0002-3295-8702
Xueqin QianDepartment of Clinical Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Li LiuDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Jianjun SunDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Wei SongDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Tangkai QiDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Zhenyan WangDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Yang TangDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Shuibao XuDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Junyang YangDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Jiangrong WangDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Jun ChenDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Renfang ZhangDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Zhaoqin ZhuDepartment of Clinical Laboratory, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Yinzhong ShenDepartment of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.ORCID 0000-0002-7604-5139
Shanghai Public Health Clinical Center · CN

Funding

Shanghai Municipal Science and Technology Critical Special Project "Research on Key Technologies for Prevention and Control of Major Sudden Infectious Diseases" ZD2021CY001Shanghai Science and Technology Commission Medical Innovation Research Special Major Project 21Y31900400Shanghai Science and Technology Commission Shanghai infectious diseases (AIDS) Clinical Medical Research Center Project 20MC1920100Shenkang Hospital Development Center Clinical Research Basic Support Project SHDC2020CR6025Shenkang Hospital Development Center Clinical Science and Technology Innovation Project SHDC22021317
6 · The paper itself

Abstract

Trends in and risk factors for drug resistance in

Indexed as

Antitubercular AgentsHIV InfectionsMicrobial Sensitivity TestsMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdultAgedChinaCoinfectionDrug Resistance, BacterialDrug Resistance, Multiple, BacterialFemaleHumansMaleMiddle AgedRisk FactorsAntitubercular AgentsHIVMycobacterium tuberculosisquinolonerifampicin

Identifiers

PMID38675968
PMCPMC11054988
OpenAlexW4394919845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.